X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6502) 6502
Book Review (1915) 1915
Book / eBook (1426) 1426
Publication (610) 610
Book Chapter (49) 49
Conference Proceeding (20) 20
Dissertation (13) 13
Magazine Article (4) 4
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6154) 6154
humans (5948) 5948
female (4136) 4136
cancer (3225) 3225
oncology (2809) 2809
middle aged (2637) 2637
aged (2245) 2245
male (2112) 2112
adult (2008) 2008
prognosis (1677) 1677
tumors (1521) 1521
pathology (1411) 1411
carcinoma (1244) 1244
carcinoma, ovarian epithelial (1235) 1235
animals (1219) 1219
ovarian cancer (1215) 1215
ovarian neoplasms - pathology (1086) 1086
diagnosis (1054) 1054
immunohistochemistry (1034) 1034
neoplasm staging (1029) 1029
neoplasms, glandular and epithelial - pathology (1026) 1026
aged, 80 and over (996) 996
research (928) 928
ovarian neoplasms - mortality (922) 922
neoplasms, glandular and epithelial - mortality (920) 920
surgery (891) 891
analysis (860) 860
neoplasms (848) 848
expression (826) 826
chemotherapy (777) 777
risk factors (756) 756
survival (737) 737
medicine & public health (733) 733
metastasis (729) 729
retrospective studies (711) 711
obstetrics & gynecology (667) 667
health aspects (664) 664
abridged index medicus (645) 645
care and treatment (641) 641
mice (596) 596
cell line, tumor (569) 569
medicine (556) 556
adenocarcinoma (549) 549
development and progression (549) 549
adenocarcinoma - pathology (543) 543
prostate cancer (539) 539
survival rate (533) 533
breast cancer (530) 530
therapy (498) 498
treatment outcome (494) 494
gene expression (480) 480
ovarian neoplasms - drug therapy (479) 479
disease-free survival (473) 473
kaplan-meier estimate (470) 470
neoplasms, glandular and epithelial - drug therapy (468) 468
survival analysis (464) 464
genetic aspects (462) 462
women (447) 447
gene expression regulation, neoplastic (439) 439
breast-cancer (436) 436
ovarian neoplasms - genetics (428) 428
article (427) 427
mortality (426) 426
biomarkers, tumor - metabolism (424) 424
diseases (419) 419
cell biology (418) 418
young adult (400) 400
neoplasms, glandular and epithelial - genetics (398) 398
proteins (397) 397
risk (394) 394
adolescent (383) 383
cells (379) 379
disease progression (372) 372
neoplasms, glandular and epithelial - surgery (364) 364
prostatic neoplasms - pathology (362) 362
hematology, oncology and palliative medicine (350) 350
biomarkers, tumor - analysis (349) 349
oncology, experimental (348) 348
ovarian neoplasms - metabolism (345) 345
medical prognosis (344) 344
ovarian neoplasms - surgery (343) 343
cancer research (340) 340
follow-up studies (330) 330
neoplasm invasiveness (327) 327
carcinogenesis (323) 323
neoplasms, glandular and epithelial - metabolism (323) 323
proportional hazards models (323) 323
epithelial ovarian cancer (318) 318
research article (315) 315
apoptosis (312) 312
biomarkers (308) 308
biopsy (302) 302
stomach neoplasms - pathology (301) 301
mutation (294) 294
gastroenterology & hepatology (289) 289
breast neoplasms - pathology (284) 284
obstetrics and gynecology (276) 276
neoplasm metastasis (274) 274
epidemiology (272) 272
biomarkers, tumor - genetics (271) 271
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (1191) 1191
Collection Dvlpm't (Acquisitions) - Closed Orders (55) 55
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (38) 38
UTL at Downsview - May be requested (32) 32
Collection Dvlpm't (Acquisitions) - Vendor file (27) 27
Scarborough Hospital - General (14) 14
Humber River Regional Hospital - Finch Stacks (11) 11
Scarborough Hospital - Birchmount (11) 11
St. Michael's Hospital - Stacks (11) 11
Markham Stouffville Hospital - Stacks (10) 10
UofT at Mississauga - Stacks (10) 10
Dentistry (Harry R Abbott) - Stacks (9) 9
Gerstein Science - Circulation Desk (9) 9
Online Resources - Online (9) 9
Credit Valley Hospital - Stacks (8) 8
Mt Sinai Hospital - Pathology (8) 8
Humber River Regional Hospital - Church Stacks (7) 7
Lakeridge Health Sciences - Oshawa (7) 7
Providence Healthcare - Reference (5) 5
Providence Healthcare - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Women's College Hospital - Stacks (4) 4
Dentistry (Harry R Abbott) - Withdrawn (3) 3
Gerstein Science - Reference (3) 3
St Josephs Health Centre - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Toronto East General Hospital - Stacks (3) 3
West Park Healthcare Centre - Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Credit Valley Hospital - Reference (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
New College (Ivey) - Stacks (2) 2
Scarborough Hospital - Hospital Department (2) 2
St. Michael's Hospital - Circulation Desk (2) 2
Trillium Health Centre - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Credit Valley Hospital - Special Collections (1) 1
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Faculty of Information - Subject Analysis Systems (1) 1
Gerstein Science - Cancelled Order (1) 1
Gerstein Science - Not Returned (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Markham Stouffville Hospital - Storage (1) 1
Providence Healthcare - Withdrawn (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Missing (1) 1
Toronto East General Hospital - Online (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
Victoria University Emmanuel College - Birge Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7910) 7910
German (33) 33
Spanish (31) 31
Chinese (18) 18
French (13) 13
Japanese (5) 5
Italian (4) 4
Polish (4) 4
Turkish (4) 4
Hungarian (3) 3
Russian (3) 3
Arabic (2) 2
Danish (2) 2
Dutch (2) 2
Czech (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 3, pp. 230 - 240
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1207 - 1214
Summary Background Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is an anti-angiogenic agent with activity against VEGF receptor (VEGFR) 1,... 
Hematology, Oncology and Palliative Medicine | TRIAL | POLY(ADP-RIBOSE) POLYMERASE | ONCOLOGY | BEVACIZUMAB | DOWN-REGULATION | FALLOPIAN-TUBE | OPEN-LABEL | EPITHELIAL OVARIAN | MAINTENANCE THERAPY | PRIMARY PERITONEAL | NEGATIVE BREAST-CANCER | Piperazines - administration & dosage | Confidence Intervals | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Aged | Women | Antimitotic agents | Relapse | Oncology, Experimental | Research | Antineoplastic agents | Vascular endothelial growth factor | Sugars | Cancer | Diseases | Monosaccharides | Ovarian cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2473 - 2483
Incorporating bevacizumab in a chemotherapy regimen (7.5 mg/kg every 3 weeks for five or six cycles) and then continuing bevacizumab alone for a total of 12... 
ANTIANGIOGENIC THERAPY | MEDICINE, GENERAL & INTERNAL | ASCITES | SOLID TUMORS | FACTOR EXPRESSION | PHASE-II | MONOCLONAL-ANTIBODY | PROGNOSTIC-SIGNIFICANCE | TUMOR ANGIOGENESIS | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Ovarian Neoplasms - mortality | Bevacizumab | Young Adult | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Carboplatin - administration & dosage | Combined Modality Therapy | Neoplasms, Glandular and Epithelial - surgery | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Quality of Life | Aged | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Intravenous administration | Body weight | Cancer therapies | Survival | Patients | Angiogenesis | Chemotherapy | Surgery | Paclitaxel | Monoclonal antibodies | Carboplatin | Vascular endothelial growth factor | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2484 - 2496
The addition of bevacizumab to chemotherapy (15 mg/kg for six cycles) followed by extended therapy with bevacizumab every 3 weeks for a total of 15 months of... 
CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | SOLID TUMORS | ANGIOGENESIS | CYCLOPHOSPHAMIDE | EXPRESSION | INTRAPERITONEAL CISPLATIN | III TRIAL | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Bevacizumab | Disease-Free Survival | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Carcinoma, Ovarian Epithelial | Quality of Life | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Risk groups | Body weight | Clinical trials | Survival | Angiogenesis | Chemotherapy | Womens health | Paclitaxel | Carboplatin | Vascular endothelial growth factor | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2014, Volume 26, Issue 3, pp. 344 - 357
Journal Article
Cancer Research, ISSN 0008-5472, 12/2013, Volume 73, Issue 23, pp. 6900 - 6912
The tumor microenvironment mediates induction of the immunosuppressive programmed cell death-1 (PD-1) pathway, and targeted interventions against this pathway... 
ACTIVATION | DENDRITIC CELLS | ONCOLOGY | GM-CSF | TOLERANCE | IN-VIVO | REGULATORY T